학술논문

ARCHER: DACOMITINIB (D; PF-00299804) VERSUS ERLOTINIB (E) FOR ADVANCED (ADV) NSCLC; A RANDOMIZED DOUBLE-BLIND PHASE III STUDY
Document Type
Journal
Source
ANNALS OF ONCOLOGY; OCT 2012, 23 p22-p23, 2p. Supplement: 11
Subject
Language
English
ISSN
09237534